Effectiveness of live attenuated influenza vaccine and inactivated influenza vaccine in children 2-17 years of age in 2013-2014 in the United States.
AUTHORS
Caspard
H ,
Gaglani
M ,
Clipper
L ,
Belongia
EA ,
McLean
HQ ,
Griffin
MR ,
Talbot
HK ,
Poehling
KA ,
Peters
TR ,
Veney
N ,
Ambrose
CS ,
. Vaccine. 2015 11 14; ().
- NIHMSID: 8406899
ABSTRACT
A postmarketing observational study was initiated to evaluate quadrivalent live attenuated influenza vaccine (LAIV) effectiveness in children aged 2-17 years in the United States.
A postmarketing observational study was initiated to evaluate quadrivalent live attenuated influenza vaccine (LAIV) effectiveness in children aged 2-17 years in the United States.
Tags: Faculty Publications 2015